Lenacapavir is a US Food and Drug Administration (FDA) approved medication indicated for the treatment of HIV type 1 (HIV-1) infection in heavily treatment-experienced adults facing multi-drug resistant HIV-1. The Dr. Reddy’s stock price settled at ₹6,750.85 on the NSE on Tuesday (October 1).
